The anti-obesity effects of GFPA were found to be related to the inhibition of Cer, via the downregulation of TLR4-mediated pro-inflammatory signaling cascades in mice with DIO. This evidence concerns the gene CBLN1 and obesity due to melanocortin 4 receptor deficiency.